News | January 26, 2024
Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
Gabapentin is indicated for the management of Postherpetic Neuraligia
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
An accomplished R&D leader and champion of the application of AI to drug discovery
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Subscribe To Our Newsletter & Stay Updated
